Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial

• Published in: The EPMA journal Vol. 11; no. 1; pp. 31 - 51
• Main Authors: Song, Eun-Ji, Han, Kyungsun, Lim, Tae-Joong, Lim, Sanghyun, Chung, Myung-Jun, Nam, Myung Hee, Kim, Hojun, Nam, Young-Do
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.03.2020; BioMed Central Ltd; Springer Nature B.V
• Subjects: Biomedical and Life Sciences; Biomedicine; Blood glucose; Body mass index; Body weight; CAT scans; Clinical trials; Diseases; Double-blind studies; Glucose; Health risk assessment; Insulin; Medicine/Public Health; Microbiota (Symbiotic organisms); Obesity; Physiological aspects; Precision medicine; Probiotics; Tomography; Type 2 diabetes; South Korea; Probiotics; Obesity; Clinical trial; Gut microbial enterotype; Predictive preventive personalized medicine

Background Prevention and improvement of disease symptoms are important issues, and probiotics are suggested as a good treatment for controlling the obesity. Human gut microbiota has different community structures. Because gut microbial composition is assumed to be linked to probiotic function, this...